Atreca (FRA:0C1) Total Liabilities : €14.60 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Atreca Total Liabilities?

Atreca's Total Liabilities for the quarter that ended in Sep. 2023 was €14.60 Mil.

Atreca's quarterly Total Liabilities declined from Mar. 2023 (€68.61 Mil) to Jun. 2023 (€64.98 Mil) and declined from Jun. 2023 (€64.98 Mil) to Sep. 2023 (€14.60 Mil).

Atreca's annual Total Liabilities increased from Dec. 2020 (€24.67 Mil) to Dec. 2021 (€39.94 Mil) and increased from Dec. 2021 (€39.94 Mil) to Dec. 2022 (€72.33 Mil).

Atreca Total Liabilities Historical Data

The historical data trend for Atreca's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca Total Liabilities Chart

Atreca Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

188.74

7.89

24.67

39.94

72.33

Atreca Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial															76.58	72.33	68.61	64.98	14.60

Atreca Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Atreca's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.381	+	(56.952	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	72.33

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	146.348	-	74.015
	=	72.33

Atreca's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.601	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	14.60

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	24.682	-	10.081
	=	14.60

Atreca Total Liabilities Related Terms

Thank you for viewing the detailed overview of Atreca's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Atreca (FRA:0C1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BCEL:USA 0C1:Germany

Address

835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.atreca.com

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines